Symposium - European Medical Journal

Continue

Symposiums

Flagship Journal
7 Mins
12 Dec 2024

Targeting IgAN with Sparsentan + a SGLT2i

IgA nephropathy (IgAN) can impact life expectancy in those affected, thus efficacious treatment is key. Endothelin 1 (ET-1) and angiotensin…
Dermatology
9 Mins
7 Nov 2024

Epigenetics to Reverse Skin Ageing

​​Epigenetic changes drive skin aging by silencing the expression of youthful genes. Experts discussed the discovery of epicelline, an…
Dermatology
11 Mins
7 Nov 2024

Vitiligo, Beyond White Patches

​​A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
Dermatology
6 Mins
7 Nov 2024

Mechanisms of Response to Bimekizumab for Psoriatic Disease

​Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based on…
Oncology
10 Mins
29 Oct 2024

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…
Oncology
8 Mins
29 Oct 2024

Patient-Centred Therapies for mNSCLC

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…
Oncology
5 Mins
29 Oct 2024

Synergy of Tumour and Liquid Biopsy

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the goal of…
Oncology
9 Mins
29 Oct 2024

Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond

At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, the latest advancements in immunotherapy for…
We’ve noticed you’re accessing
from North/South America.